Helens International Holdings Full Year 2023 Earnings: Misses Expectations

Helens International Holdings (HKG:9869) Full Year 2023 Results

Key Financial Results

• Revenue: CN¥1.21b (down 23% from FY 2022).
• Net income: CN¥180.5m (up from CN¥1.60b loss in FY 2022).
• Profit margin: 15% (up from net loss in FY 2022).
• EPS: CN¥0.14 (up from CN¥1.46 loss in FY 2022).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Helens International Holdings Revenues and Earnings Miss Expectations

Revenue missed analyst estimates by 16%. Earnings per share (EPS) also missed analyst estimates by 27%.

Looking ahead, revenue is forecast to grow 15% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Hospitality industry in Hong Kong.

Performance of the Hong Kong Hospitality industry.

The company's shares are down 23% from a week ago.

Risk Analysis

It's necessary to consider the ever-present spectre of investment risk. We've identified 2 warning signs with Helens International Holdings (at least 1 which is a bit concerning), and understanding these should be part of your investment process.

Valuation is complex, but we're here to simplify it.

Discover if Helens International Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.